Trials / Withdrawn
WithdrawnNCT04149379
Hyperbaric Oxygen Therapy After Stroke - PILOT
Hyperbaric Oxygen Therapy After Cerebral Infarction - PILOT
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Norwegian Underwater Intervention (NUI) · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this pilot study is to establish more information about hyperbaric oxygen therapy for this group of patients, and give us more information of how to initiate the best possible main study. Can we find any indications that support the use of this therapy for patients suffering from chronic disability after cerebral infarction? Can we improve physical and cognitive function.
Detailed description
This is a pilot project including 6 patients for one session of 20 treatments of hyperbaric oxygen therapy. The objective is to establish knowledge of HBO for this group of patients in a Norwegian context, so that we can prepare for the main study afterwards, including about 60-70 patients. We need to know how to optimize the administrative and technical systems for the larger study. We want to collect feedback from the patients undergoing the pilot study. We want more information about the treatment table, if 20 treatments are enough, if 2,4 bar pressure is adequate. The treatment table is based on existing research, and is considered safe. The patients are to be treated at table 14/90, at 2,4 Absolute atmospheres, and daly 90 minutes of oxygen inhalation (medical oxygen).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyperbaric oxygen | 20 sessions of hyperbaric therapy in a pressure chamber at 2,4 absolute atmospheres, 90 minutes per day of breathing 100% medical oxygen through an own mask. Table 14/90. |
Timeline
- Start date
- 2020-04-20
- Primary completion
- 2021-08-31
- Completion
- 2021-12-20
- First posted
- 2019-11-04
- Last updated
- 2020-04-27
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT04149379. Inclusion in this directory is not an endorsement.